<SEC-DOCUMENT>0001104659-23-080025-index.html : 20230711 <SEC-HEADER>0001104659-23-080025.hdr.sgml : 20230711 <ACCEPTANCE-DATETIME>20230711171355 ACCESSION NUMBER: 0001104659-23-080025 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20230711 FILED AS OF DATE: 20230711 DATE AS OF CHANGE: 20230711 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0000707511 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521253406 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-15070 FILM NUMBER: 231082750 BUSINESS ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-208-9191 MAIL ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC DATE OF NAME CHANGE: 19950719 </SEC-HEADER> <DOCUMENT> <TYPE>DEF 14A <SEQUENCE>1 <FILENAME>tm2319588d2_def14a.htm <DESCRIPTION>DEF 14A <TEXT> Document 1 - file: tm2319588d2_def14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>tm2319588d2_def14aimg001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: tm2319588d2_def14aimg001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>tm2319588d2_def14aimg002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: tm2319588d2_def14aimg002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>tmb-20230711xcoverg001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: tmb-20230711xcoverg001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>tmb-20230711xcoverg002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: tmb-20230711xcoverg002.jpg
</DOCUMENT> </SEC-DOCUMENT>